KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Capital Expenditures: 2009-2025

Historic Capital Expenditures for Cme Group (CME) over the last 16 years, with Sep 2025 value amounting to $18.4 million.

  • Cme Group's Capital Expenditures fell 38.26% to $18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.2 million, marking a year-over-year decrease of 12.87%. This contributed to the annual value of $94.0 million for FY2024, which is 23.04% up from last year.
  • Cme Group's Capital Expenditures amounted to $18.4 million in Q3 2025, which was down 0.00% from $18.4 million recorded in Q2 2025.
  • In the past 5 years, Cme Group's Capital Expenditures ranged from a high of $39.7 million in Q2 2021 and a low of $14.2 million during Q1 2025.
  • In the last 3 years, Cme Group's Capital Expenditures had a median value of $19.8 million in 2024 and averaged $20.1 million.
  • As far as peak fluctuations go, Cme Group's Capital Expenditures slumped by 61.00% in 2021, and later spiked by 49.75% in 2024.
  • Quarterly analysis of 5 years shows Cme Group's Capital Expenditures stood at $27.3 million in 2021, then decreased by 10.62% to $24.4 million in 2022, then decreased by 14.75% to $20.8 million in 2023, then rose by 25.96% to $26.2 million in 2024, then slumped by 38.26% to $18.4 million in 2025.
  • Its last three reported values are $18.4 million in Q3 2025, $18.4 million for Q2 2025, and $14.2 million during Q1 2025.